Clinical Trials Directory

A Pilot Study to Assess the Utility of Indocyanine Green? (IC-GREEN?) SPY Imaging in the Mapping of Arm Draining Lymphatics and Nodes During Sentinel Node Resection With or Without Axillary Dissection in Breast Cancer

To determine concordance between isosulfan blue (ISB) and indocyanine green (IC-GREEN?) in the identification of lymphatics and arm-draining nodes during nodal staging procedures in breast cancer.

Stanford is now accepting new patients for this trial. Please contact Shannon Meyer at 650-724-1953 for more information.



  • device : (IC-GREEN?) SPY Elite® Imaging

Phase: N/A


Ages Eligible For Study:

18 Years - 90 Years

Inclusion Criteria

- Ability to understand and the willingness to sign a written informed consent document. - Signed written informed consent. - Women undergoing sentinel lymph node biopsy. - Women with breast cancer with known or suspected lymph node involvement. - Women undergoing sentinel node identification and completion axillary lymph node dissection. - Women of 18 years of age or older. - Eastern Cooperative Oncology Group (ECOG) or Karnofsky Performance Status 0,1,2. - Complete Blood Count (CBC) and basic Metabolic Panel within 6 months

External Links

Explore related trials

Contact information

Primary Contact:

Shannon Meyer 650-724-1953

Stanford University School of Medicine 300 Pasteur Drive Stanford, CA 94305

Stanford Medicine Resources:

Footer Links: